| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |